Cabot Co. (NYSE:CBT – Get Free Report) announced a quarterly dividend on Friday, November 8th,RTT News reports. Investors of record on Friday, November 29th will be given a dividend of 0.43 per share by the specialty chemicals company on Friday, December 13th. This represents a $1.72 annualized dividend and a yield of 1.57%. The ex-dividend date is Friday, November 29th.
Cabot has increased its dividend payment by an average of 3.9% annually over the last three years and has raised its dividend every year for the last 13 years. Cabot has a dividend payout ratio of 22.5% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Cabot to earn $8.48 per share next year, which means the company should continue to be able to cover its $1.72 annual dividend with an expected future payout ratio of 20.3%.
Cabot Price Performance
Shares of NYSE CBT opened at $109.50 on Thursday. The stock has a market cap of $5.96 billion, a P/E ratio of 16.25, a P/E/G ratio of 0.97 and a beta of 1.20. The firm’s 50-day simple moving average is $111.04 and its 200 day simple moving average is $102.82. Cabot has a fifty-two week low of $70.63 and a fifty-two week high of $117.46. The company has a quick ratio of 1.36, a current ratio of 2.08 and a debt-to-equity ratio of 0.68.
Analyst Ratings Changes
Several research firms have issued reports on CBT. UBS Group dropped their price target on Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a report on Tuesday, August 6th. Mizuho boosted their target price on Cabot from $103.00 to $122.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 5th. Finally, JPMorgan Chase & Co. downgraded Cabot from a “neutral” rating to an “underweight” rating and set a $105.00 target price for the company. in a report on Monday, November 11th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Cabot currently has an average rating of “Hold” and a consensus price target of $105.00.
View Our Latest Stock Analysis on CBT
Insider Buying and Selling
In related news, EVP Hobart Kalkstein sold 34,759 shares of the stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $115.23, for a total value of $4,005,279.57. Following the completion of the sale, the executive vice president now directly owns 50,627 shares of the company’s stock, valued at approximately $5,833,749.21. This represents a 40.71 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Jeff Ji Zhu sold 14,566 shares of Cabot stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $113.25, for a total value of $1,649,599.50. Following the transaction, the executive vice president now directly owns 69,449 shares in the company, valued at approximately $7,865,099.25. This trade represents a 17.34 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 75,807 shares of company stock valued at $8,352,941. Company insiders own 3.07% of the company’s stock.
About Cabot
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
See Also
- Five stocks we like better than Cabot
- Do ETFs Pay Dividends? What You Need to Know
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is the S&P/TSX Index?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.